Table 3.
LTR-driven LncRNAs with oncogenic role
| lncRNAa | TE type | TE promoter coordinates (hg38) | Cancer type | references |
|---|---|---|---|---|
| SchLAP1 | (ERV1) LTR12C | chr2:180691205–180692425 | prostate | [143] |
| ROR | (ERV1) LTR7 | chr18:57072052–57072502 | breast, others | [147, 150] |
| HOST2 | (ERV1) LTR2B | chr10:84171987–84172465 | ovarian | [154] |
| AFAP1-AS1 | (ERVL-MaLR) THE1A LTRb | chr4:7753884–7754236 | several | [156, 158] |
| SAMMSON | (ERV1) LTR1A2b | chr3:69999501–70000359 | melanoma | [161] |
| HULC | (ERVL-MaLR) MLT1A LTR | chr6:8652095–8652454 | liver | [163] |
| UCA1 | (ERV1) LTR7C | chr19:15828738–15829200 | several | [165, 167] |
| BANCR | (ERV1) MER41B LTR | chr9:69306939–69307567 | melanoma, others | [169] |
aOnly those cases with supporting evidence of a role in the cancer are listed
bThe fact that the promoter is an LTR was not previously noted